1. Home
  2. UPLD vs LCTX Comparison

UPLD vs LCTX Comparison

Compare UPLD & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPLD
  • LCTX
  • Stock Information
  • Founded
  • UPLD 2010
  • LCTX 1990
  • Country
  • UPLD United States
  • LCTX United States
  • Employees
  • UPLD N/A
  • LCTX N/A
  • Industry
  • UPLD Computer Software: Prepackaged Software
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UPLD Technology
  • LCTX Health Care
  • Exchange
  • UPLD Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • UPLD 115.3M
  • LCTX 118.8M
  • IPO Year
  • UPLD 2014
  • LCTX N/A
  • Fundamental
  • Price
  • UPLD $2.88
  • LCTX $0.41
  • Analyst Decision
  • UPLD Hold
  • LCTX Strong Buy
  • Analyst Count
  • UPLD 3
  • LCTX 5
  • Target Price
  • UPLD $3.75
  • LCTX $4.20
  • AVG Volume (30 Days)
  • UPLD 192.4K
  • LCTX 1.8M
  • Earning Date
  • UPLD 03-12-2025
  • LCTX 03-10-2025
  • Dividend Yield
  • UPLD N/A
  • LCTX N/A
  • EPS Growth
  • UPLD N/A
  • LCTX N/A
  • EPS
  • UPLD N/A
  • LCTX N/A
  • Revenue
  • UPLD $274,794,000.00
  • LCTX $9,499,000.00
  • Revenue This Year
  • UPLD N/A
  • LCTX $25.10
  • Revenue Next Year
  • UPLD N/A
  • LCTX $35.67
  • P/E Ratio
  • UPLD N/A
  • LCTX N/A
  • Revenue Growth
  • UPLD N/A
  • LCTX 6.19
  • 52 Week Low
  • UPLD $1.79
  • LCTX $0.40
  • 52 Week High
  • UPLD $5.64
  • LCTX $1.56
  • Technical
  • Relative Strength Index (RSI)
  • UPLD 34.86
  • LCTX 26.71
  • Support Level
  • UPLD $3.23
  • LCTX $0.47
  • Resistance Level
  • UPLD $3.48
  • LCTX $0.55
  • Average True Range (ATR)
  • UPLD 0.22
  • LCTX 0.04
  • MACD
  • UPLD -0.00
  • LCTX -0.00
  • Stochastic Oscillator
  • UPLD 6.02
  • LCTX 8.18

About UPLD Upland Software Inc.

Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: